13F Holdings
中文EN

UAN CVR PARTNERS, LP

Agricultural Chemicals · NYSE · SEC CIK 1425292 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.3%
TTM net income YoY-16.4%
TTM EPS YoY-16.4%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR-25.5%

Margins

Gross margin26.5%
Operating margin20.6%
Net margin16.1%
FCF margin22.6%
EBITDA margin34.0%

Returns

ROE—
ROA10.2%
ROIC (approx.)—
Asset turnover0.63x

Leverage & solvency

Liabilities / assets—
Debt / equity—
Current ratio1.65x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.23x
Accruals ratio-12.5%
Payout ratio—
Capex / revenue13.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$606.04M$525.32M$681.48M$835.58M$532.58M
Cost of revenue$442.67M$406.46M$449.01M$483.22M$370.54M
Gross profit$163.37M$118.86M$232.46M$352.37M$162.04M
SG&A expense$33.59M$28.41M$29.52M$32.19M$26.61M
Operating income$128.66M$90.35M$201.41M$319.91M$134.48M
Pretax income$98.64M$60.98M$172.72M$286.96M$78.21M
Income tax-$23,000$77,000$289,000$160,000$57,000
Net income$98.66M$60.90M$172.43M$286.80M$78.16M
EBITDA$210.53M$178.45M$281.13M$402.05M$207.96M
EPS (basic)9.335.7616.3127.077.31
EPS (diluted)9.335.7616.3127.077.31
Weighted avg. shares (diluted)10.57M10.57M10.57M10.59M10.69M
Banking
Net interest income——-$28.65M-$34.06M-$60.98M
Balance sheet
Cash & equivalents$69.24M$90.86M$45.28M$86.34M$112.52M
Receivables$58.96M$65.22M$41.89M$90.45M$88.35M
Inventory$82.68M$75.58M$69.17M$77.52M$52.27M
Current assets$213.87M$233.54M$165.87M$265.70M$262.25M
PP&E, net$711.82M$735.59M$761.02M$810.99M$850.46M
Goodwill———$0$0
Total assets$969.46M$1.02B$975.33M$1.10B$1.13B
Current liabilities$96.77M$111.35M$75.47M$126.06M$161.86M
Short-term debt$778,000$877,000$0—$0
Long-term debt$569.07M$567.97M$547.31M$546.80M$610.64M
Total debt$569.85M$568.85M$547.31M$546.80M$610.64M
Shareholders' equity—————
Net debt$500.60M$477.99M$502.03M$460.46M$498.13M
Cash flow statement
Operating cash flow$149.64M$150.54M$243.53M$301.46M$188.72M
Capital expenditure$50.80M$37.07M$24.20M$44.67M$20.59M
Free cash flow$98.84M$113.47M$219.33M$256.80M$168.13M
Investing cash flow-$44.09M-$31.89M-$2.72M-$44.62M-$20.34M
Financing cash flow-$127.17M-$73.07M-$281.86M-$283.02M-$86.43M
Depreciation & amortization$81.87M$88.10M$79.72M$82.14M$73.48M
Stock-based compensation$9.80M$4.90M$8.23M$25.26M$23.07M
Share buybacks—$0$0$12.40M$529,000

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.